Question: Montana Subscriber Answer: • 96413 (Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug) for the infusion session • J1745 (Injection, infliximab, 10 mg) x 8 for the Remicade supply • 555.1 (Regional enteritis; large intestine) appended to 96413 to represent the patent's Crohn's disease • J1756 (Injection, iron sucrose, 1 mg) x 50 for the Venofer • 280.8 (Iron deficiency anemias; other specified iron deficiency anemias) appended to J1756 to represent the patient's Plummer-Vinson syndrome.